Invicta Diagnostic Ltd

NSE: INVICTA · Healthcare · 7 announcements

Share price: ₹70.00
Market cap: ₹88.00 Cr
Revenue (annual): ₹32.35 Cr
Net profit (annual): ₹4.91 Cr
P/E (TTM): 17.9×Sector 57.8×
Promoter holding: 66.70%
FII holding: 4.20%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Sep 2026 13:37 IST NSE

Board Meeting Outcome

Invicta Diagnostic Board Meeting Outcome

Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.

Read the filing ↗